John Canan
Patrimonio netto: 4 M $ in data 31/07/2026
Patrimonio netto: 4 M $ in data 31/07/2026
John Canan worked for Merck & Co., Inc. as Senior VP-Finance & Global Controller from 2014 to 2014.
He also worked for Schering-Plough Corp.
as Chief Accounting Officer, SVP & Global Controller from 2009 to 2009, and for Merck Sharp & Dohme Corp.
as Senior Vice President & Controller from 2009 to 2009.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
Terex Corp.
Terex Corp. Trucks/Construction/Farm MachineryProducer Manufacturing Manufactures and markets aerial work platforms and materials processing machinery 0,06% | 27/04/2026 | 64.456 ( 0,06% ) | 4 M $ | 31/07/2026 |
| Società | Posizione | Fine |
|---|---|---|
| MERCK & CO., INC. | Comptroller/Controller/Auditor | 01/03/2014 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Comptroller/Controller/Auditor | 03/11/2009 |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Comptroller/Controller/Auditor | 01/11/2009 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Merck Sharp & Dohme Corp.
Merck Sharp & Dohme Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale